These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24270605)

  • 1. Discovery and development of first in class antifungal caspofungin (CANCIDAS®)--a case study.
    Balkovec JM; Hughes DL; Masurekar PS; Sable CA; Schwartz RE; Singh SB
    Nat Prod Rep; 2014 Jan; 31(1):15-34. PubMed ID: 24270605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of the antifungal beta-1,3-glucan synthase inhibitor CANCIDAS (caspofungin acetate) from pneumocandin B0.
    Leonard WR; Belyk KM; Conlon DA; Bender DR; DiMichele LM; Liu J; Hughes DL
    J Org Chem; 2007 Mar; 72(7):2335-43. PubMed ID: 17343416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering of Glarea lozoyensis for exclusive production of the pneumocandin B0 precursor of the antifungal drug caspofungin acetate.
    Chen L; Yue Q; Li Y; Niu X; Xiang M; Wang W; Bills GF; Liu X; An Z
    Appl Environ Microbiol; 2015 Mar; 81(5):1550-8. PubMed ID: 25527531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspofungin: an overview.
    Morrison VA
    Expert Rev Anti Infect Ther; 2005 Oct; 3(5):697-705. PubMed ID: 16207161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering of New Pneumocandin Side-Chain Analogues from Glarea lozoyensis by Mutasynthesis and Evaluation of Their Antifungal Activity.
    Chen L; Li Y; Yue Q; Loksztejn A; Yokoyama K; Felix EA; Liu X; Zhang N; An Z; Bills GF
    ACS Chem Biol; 2016 Oct; 11(10):2724-2733. PubMed ID: 27494047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of pneumocandin lipopeptides and perspectives for its production and related echinocandins.
    Li Y; Lan N; Xu L; Yue Q
    Appl Microbiol Biotechnol; 2018 Dec; 102(23):9881-9891. PubMed ID: 30255232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic colisporifungin and linear cavinafungins, antifungal lipopeptides isolated from Colispora cavincola.
    Ortíz-López FJ; Monteiro MC; González-Menéndez V; Tormo JR; Genilloud O; Bills GF; Vicente F; Zhang C; Roemer T; Singh SB; Reyes F
    J Nat Prod; 2015 Mar; 78(3):468-75. PubMed ID: 25636062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antifungal activities of glycosylated derivatives of the cyclic peptide fungicide caspofungin.
    Guo J; Hu H; Zhao Q; Wang T; Zou Y; Yu S; Wu Q; Guo Z
    ChemMedChem; 2012 Aug; 7(8):1496-503. PubMed ID: 22684908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomics-driven discovery of the pneumocandin biosynthetic gene cluster in the fungus Glarea lozoyensis.
    Chen L; Yue Q; Zhang X; Xiang M; Wang C; Li S; Che Y; Ortiz-López FJ; Bills GF; Liu X; An Z
    BMC Genomics; 2013 May; 14():339. PubMed ID: 23688303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin.
    Maschmeyer G; Glasmacher A
    Mycoses; 2005 Jul; 48(4):227-34. PubMed ID: 15982202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel osmotic stress control strategy for improved pneumocandin B
    Song P; Huang B; Zhang S; Zhang K; Yuan K; Ji X; Ren L; Wen J; Huang H
    Appl Microbiol Biotechnol; 2018 Dec; 102(24):10729-10742. PubMed ID: 30413850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9-Based Genome Editing in the Filamentous Fungus
    Wei TY; Wu YJ; Xie QP; Tang JW; Yu ZT; Yang SB; Chen SX
    ACS Synth Biol; 2020 Aug; 9(8):1968-1977. PubMed ID: 32786921
    [No Abstract]   [Full Text] [Related]  

  • 13. Pneumocandins from Zalerion arboricola. I. Discovery and isolation.
    Schwartz RE; Sesin DF; Joshua H; Wilson KE; Kempf AJ; Goklen KA; Kuehner D; Gailliot P; Gleason C; White R
    J Antibiot (Tokyo); 1992 Dec; 45(12):1853-66. PubMed ID: 1490876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual fructose and osmolality affect the levels of pneumocandins B0 and C0 produced by Glarea lozoyensis.
    Connors N; Petersen L; Hughes R; Saini K; Olewinski R; Salmon P
    Appl Microbiol Biotechnol; 2000 Dec; 54(6):814-8. PubMed ID: 11152074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutual influence of backbone proline substitution and lipophilic tail character on the biological activity of simplified analogues of caspofungin.
    Mulder MP; Fodran P; Kemmink J; Breukink EJ; Kruijtzer JA; Minnaard AJ; Liskamp RM
    Org Biomol Chem; 2012 Oct; 10(37):7491-502. PubMed ID: 22878559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of SDS on release of intracellular pneumocandin B
    Yuan K; Huang B; Qin T; Song P; Zhang K; Ji X; Ren L; Zhang S; Huang H
    Appl Microbiol Biotechnol; 2019 Aug; 103(15):6061-6069. PubMed ID: 31161390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Manipulation of the Pneumocandin Biosynthetic Pathway for Generation of Analogues and Evaluation of Their Antifungal Activity.
    Li Y; Chen L; Yue Q; Liu X; An Z; Bills GF
    ACS Chem Biol; 2015 Jul; 10(7):1702-10. PubMed ID: 25879325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glyap1 regulates pneumocandin B
    Dong Y; Zhang L; Zhang W; Cao J; Wei Y; Song P; Xu Q
    Appl Microbiol Biotechnol; 2021 Sep; 105(18):6707-6718. PubMed ID: 34476516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumocandins from Zalerion arboricola. III. Structure elucidation.
    Hensens OD; Liesch JM; Zink DL; Smith JL; Wichmann CF; Schwartz RE
    J Antibiot (Tokyo); 1992 Dec; 45(12):1875-85. PubMed ID: 1490878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology and clinical use of caspofungin.
    Hope WW; Shoham S; Walsh TJ
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):263-74. PubMed ID: 17428155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.